Haemonetics to Present at 42nd Annual J.P. Morgan Healthcare Conference

BOSTON, Dec. 7, 2023

The public may access Mr. Simon's presentation live via audio webcast at:
https://jpmorgan.metameetings.net/events/healthcare24/sessions/49347-haemonetics-corporation/webcast?gpu_only=true&kiosk=true

The live webcast can also be accessed under the Events & Presentations section of the Company's Investor Relations website. The replay of the presentation will be available for 30 days using the link provided above and on Investor Relations website shortly after the live event.

ABOUT HAEMONETICS
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:
Olga Guyette, Sr. Director-Investor Relations & Treasury ARIVA.DE Börsen-Geflüster Kurse Haemonetics 90,99 $ +3,80%	David Trenk, Manager-Investor Relations
(781) 356-9763	(203) 733-4987
olga.guyette@haemonetics.com	david.trenk@haemonetics.com
Media Contact: Josh Gitelson, Director-Global Communications (781) 356-9776 josh.gitelson@haemonetics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-to-present-at-42nd-annual-jp-morgan-healthcare-conference-302009459.html

SOURCE Haemonetics Corporation